Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1661059 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $6.78 · Day +1.95% · Mkt cap $30M · 1Y +33.2% · Off 52W high −56.9% · Vol (1Y) 243.4% Price2023-08-21 → 2026-08-19 NXTC close: $18.8 on 2023-08-21 to $6.8 on 2026-08-19. Split-adj closes · 240 of 1,825 · price returnⓘ At a glance | Short interest3.1% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−0.09% | | Top-10 13F concentration84.4% | | Next report (est.)2026-11-05 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$42.7M | | ROE−111.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−52.2% | | 1Y+33.2% | | 3Y−64.0% | | 5Y−91.9% | | Since incept. (ann.)−38.7% |
Total return · from 2019-05-09ⓘ Risk | Ann. volatility (1Y)243.4% | | Ann. volatility (3Y)154.4% | | Sharpe (1Y)0.86 | | Sharpe (3Y)0.31 | | Max drawdown (1Y)−88.8% | | Max drawdown (3Y)−94.6% | | Beta (3Y vs SPY)2.32 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Squadron Capital Management LLC | 265,000 | $3M | 7.44% | +11.8% | | Affinity Asset Advisors, LLC | 241,826 | $3M | 6.79% | −2.2% | | Ikarian Capital, LLC | 238,303 | $3M | 6.69% | +0.0% | | Sofinnova Investments, Inc. | 222,654 | $2M | 6.25% | +0.0% | | SILVERARC CAPITAL MANAGEMENT, LLC | 176,057 | $2M | 4.94% | +0.0% | | VANGUARD CAPITAL MANAGEMENT LLC | 160,473 | $2M | 4.51% | new | | Pfizer Inc | 153,354 | $2M | 4.31% | −2.7% | | Opaleye Management Inc. | 141,181 | $2M | 3.97% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-06 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-06 | −$2.80 | — | — | — | | 2026-03-31 | 2026-05-07 | −$1.87 | — | — | — | | 2025-09-30 | 2025-11-05 | −$3.22 | — | — | — | | 2025-06-30 | 2025-08-07 | — | — | — | — |
As-reported XBRL · next 2026-11-05 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
